Radiology Information System Market to Reach USD 2,315.7 Million by 2032 as EHR Integration and Teleradiology Gain Momentum

The global radiology information system market is set for strong expansion as imaging volumes rise and healthcare providers digitize their workflows Kings Research reports that the market was valued at USD 1,220.2 million in 2024, is estimated at USD 1,310.1 million in 2025, and is projected to reach USD 2,315.7 million by 2032, growing at a compound annual growth rate (CAGR) of 8.48% during the 2025–2032 forecast period.

A radiology information system, or RIS, is the software backbone of a diagnostic imaging department. It manages patient scheduling, examination records, image tracking, radiologist workflows, reporting, billing, and result sharing across healthcare networks. Hospitals, diagnostic centers, and research institutions depend on these platforms to handle high imaging volumes while meeting regulatory requirements.

Market Overview

The report attributes market growth primarily to deeper integration with electronic health records (EHR) and to the rapid expansion of teleradiology and remote diagnostics. Together, these forces are improving data accessibility, workflow efficiency, and the flexibility of patient care across a wide range of settings.

Underlying demand is also being driven by the sheer number of diagnostic imaging procedures performed in hospitals and outpatient clinics. Radiology departments face pressure to process higher volumes without compromising quality, and RIS platforms help by automating scheduling, streamlining imaging workflows, and shortening turnaround times. The need to organize imaging data accurately across departments has made integrated software solutions increasingly critical.

Artificial intelligence is becoming part of the picture. In February 2025, DeepHealth, a RadNet subsidiary, unveiled AI-powered radiology informatics and population screening solutions at the European Congress of Radiology in Vienna. Built on the cloud-native DeepHealth OS, the offerings are aimed at enhancing clinical workflows and operational efficiency.

Key Highlights from the Report

North America held a 35.22% market share in 2024, valued at USD 429.8 million. The integrated RIS segment generated USD 880.6 million in revenue in 2024, while the on-premise deployment segment is expected to reach USD 931.6 million by 2032. Software secured the largest component share at 68.13% in 2024. Diagnostic imaging centers are expected to post the fastest end-user growth, with a CAGR of 10.81%, and Asia Pacific is forecast to grow at 11.62% over the forecast period, reaching about USD 734.1 million by 2032.

Market Driver: EHR Integration

The growing need for interoperability and centralized patient records is a major catalyst. When a RIS connects with an EHR platform, care teams gain seamless access to patient histories, imaging results, and treatment plans. That connectivity supports better diagnostic accuracy and more informed clinical decisions, and it helps reduce the risk of medical errors by ensuring continuity of care.

Providers are investing accordingly. In April 2024, AbbaDox partnered with Radiology Imaging Associates to integrate its RIS platform and improve radiology operations. The integration streamlines appointment scheduling and automated patient communication, and it brings tailored workflows for breast and lung health along with AI-driven follow-up recommendations.

Market Challenge: Data Security and Privacy

Because RIS platforms hold highly sensitive medical information, they are exposed to cyberattacks and data breaches that can result in legal and reputational damage. Vendors are investing in advanced encryption, strict access controls, and compliance with regional data protection rules such as HIPAA and GDPR. Ongoing employee training and regular security audits further help maintain system integrity and build trust among healthcare providers and patients.

Market Trend: Teleradiology and Remote Diagnostics

As radiologists increasingly work across geographic locations, RIS platforms provide the remote access, centralized data management, and communication tools that distributed teams require. They enable rapid sharing of imaging studies and faster report generation, and the need for scalable platforms is growing as healthcare systems embrace remote diagnostics and round-the-clock radiology coverage.

In May 2025, Konica Minolta Healthcare Americas collaborated with NewVue to launch Exa Teleradiology, powered by NewVue. The cloud-based solution is built for distributed reading environments and offers a unified platform with more comprehensive integration capabilities than typical interfaced systems.

Segmentation Insights

By product type, the integrated RIS segment led in 2024 with USD 880.6 million, thanks to its ability to combine multiple functions in one platform; it is projected to reach USD 1,594.9 million by 2032. By deployment mode, on-premise systems held a 47.12% share in 2024 because providers value control over data security, customization, and integration with existing hospital infrastructure, while cloud-based and web-based options continue to gain interest.

By component, software is projected to reach USD 1,429.1 million by 2032, owing to its central role in managing, storing, and analyzing medical imaging data. By end user, hospitals, outpatient clinics, and diagnostic imaging centers are the main groups, with imaging centers growing fastest because of their high procedure volumes and need for centralized workflow management.

Regional Analysis

North America remains the largest market. Well-established healthcare infrastructure and cutting-edge diagnostic tools create demand for sophisticated RIS solutions, and providers in the region increasingly prefer cloud-based platforms that improve data accessibility, lower IT costs, and support remote collaboration across multiple locations.

Asia Pacific is the fastest-growing region. New hospitals and diagnostic centers are opening quickly, creating strong demand for tools that manage rising imaging workloads, and several governments are promoting digital healthcare through policy frameworks and funding. In January 2025, Philips introduced its AI-enabled CT 5300 at the 23rd Asian Oceanian Congress of Radiology, a 128-slice system featuring AI reconstruction and smart workflows.

Regulatory Landscape

Regulation is a defining feature of this market. In the United States, HIPAA governs patient data privacy and security, the 21st Century Cures Act enforces interoperability and access to health data, and the Mammography Quality Standards Act sets strict standards that affect documentation and reporting. The European Union applies GDPR and classifies RIS as a medical device under Regulation (EU) 2017/745, imposing rigorous clinical evaluation and post-market surveillance. China requires data localization under its Cybersecurity Law and Data Security Law, with devices overseen by the National Medical Products Administration. Japan regulates personal health data under its Act on the Protection of Personal Information and is advancing guidelines that permit limited use of anonymized data for research and AI.

Competitive Landscape

Leading vendors are integrating AI tools, forming strategic partnerships, and improving workflow efficiency. Key companies profiled include Cerner Corporation, McKesson Corporation, Epic Systems Corporation, General Electric Company, Siemens, Koninklijke Philips N.V., IBM, Allscripts Healthcare Solutions, MedInformatix, Inc., eRAD, Inc., Pro Medicus Ltd., Carestream Health, Agfa-Gevaert Group, Sectra AB, and Intelerad.

Product activity is brisk. In November 2024, Intelerad launched InteleGence, a platform for integrating best-of-breed AI algorithms into radiology workflows. In August 2024, Pro Medicus added new capabilities to its Visage RIS to reinforce AI readiness for the Visage 7 platform, and in December 2024 Sectra presented next-generation enterprise imaging solutions at RSNA 2024, emphasizing improved diagnostic workflows and access to imaging data.

Outlook

As imaging volumes grow, care becomes more distributed, and AI moves into everyday clinical practice, the RIS is evolving from an administrative tool into a core clinical platform. Vendors that deliver secure, interoperable, cloud-ready, and AI-enabled systems are likely to capture the greatest share of the market's growth through 2032.